Aug 2017

Sale of a Utility-Ready Biologics / Vaccines Manufacturing Site

Shire Krems

PharmaBioSource provided transaction consulting services to Shire on the divestment of its 340,000 SF Krems, Austria vaccines manufacturing site to Merck Animal Health.

  • Service: Transaction Consulting
  • Sector: Biotechnology / Animal Health
  • Sub-sector: Vaccines
  • Engagement Type: Sell Side

PharmaBioSource provided comprehensive transaction services to divest Shire’s biologics / vaccines manufacturing site near Vienna, Austria.  The site was acquired by Merck Animal Health to expand its global vaccine manufacturing capacity.

PharmaBioSource’s services included a benchmark valuation, buyer target identification, creation of the confidential information memorandum (CIM), data room development and due diligence support.

Press Release